Local
Editorial: Oregon’s battle over prescription drug prices
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: The Bulletin

One battlefront of healthcare affordability is Oregon’s Prescription Drug Affordability Board. The board, created by the Legislature, does what its name says — tries to keep prescription drug prices under control. The board was working Wednesday morning to finalize its recommendations to the Legislature about what steps to take next. Organizations such as PhRMA, the Pharmaceutical Research and Manufacturers of America, and Regence Blue Cross Blue Shield, were telling the board they didn’t like some of the direction where the board wants to go. The board basically discussed four draft recommendations for Oregon legislators: Continuity. When a person switches commercial health plans their prescriptions should basically go with them, the board says. Expanded scope. The board wants the ability to look at broader practices, purchasing arrangements, patient access and more to give it added flexibility to evaluate prescription drugs costs and perhaps drive legislative changes. Orphan drugs.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at The Bulletin



